Clinical Trial

Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM

Study acronym: Air3Pilot
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, single arm, open-label, interventional, pilot study to evaluate the accuracy and precision of the continuous glucose monitoring (CGM) system of i-SENS, Inc., CareSens Air 3, in adult patients with type 1 diabetes.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-12-18; most recent amendment 2026-04-06.
Status change: Not Yet Recruiting → Recruiting 2026-02-05
Trial Details
NCT Number NCT07296276
Lead Sponsor i-SENS, Inc.
Collaborators: Integrated Medical Development
Conditions Type 1 Diabetes Mellitus
Enrollment 32 participants
Start Date 2026-02-09
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-09